[1]
M. BASHINI, S. SHAH, and C. DESAI, β€œAN EVALUATION OF ADVERSE DRUG REACTIONS WITH REMDESIVIR IN PATIENTS OF COVID-19”, Asian J Pharm Clin Res, vol. 15, no. 8, pp. 88–91, Aug. 2022.